References
- Friedman SL. Liver fibrosis – from bench to beside. J Hepatol 2003;38:S38–53.
- Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 1999;14:618–33.
- Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006;364:33–60.
- Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665–72.
- Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209–18.
- Bae KH. Dictionary of Korean Folk Medicine. Seoul: Kyu Hak Sa, 2000:317.
- Lee MK, Jeon HY, Lee KY, Kim SH, Ma CJ, Sung SH, et al. Inhibitory constituents of Euscaphis japonica on lipopolysacchride-induced nitric oxide production in BV2 microglia. Planta Med 2007;73:782–6.
- Vogel SR, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000;41:882–93.
- Lee MK, Ha NR, Yang H, Sung SH, Kim GH, Kim YC. Anti-proliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine 2008;15:775–80.
- Akihisa T, Yamamoto K, Tamura T, Kimura Y, Iida T, Nambara T, et al. Triterpenoid ketone from Lingnania chungii Mcclure: arborinone, friedelin, and glutinone. Chem Pharm Bull 1992;40:789–91.
- El-Seedi HR. Antimicrobial triterpenes from Poulsenia armata Miq. Standl. Nat Prod Res 2005;19:197–202.
- Mahaho SB, Kundu AP. 13C NMR spectra of pentacyclic triterpenoids – a complication and some salient features. Phytochemistry 1994;37:1517–75.
- Cheng DL, Cao XP. Pomolic acid derivatives from the root of Sanguisorba officinalis. Phytochemistry 1992;31:1317–20.
- Nakatani M, Miyazaki Y, Iwashita T, Naoki H, Hase T. Triterpenes from Ilex rotunda fruit. Phytochemistry 1989;23:1479–82.
- Uyama N, Shimahara Y, Okuyama H, Kawada N, Kamo S, Ikeda K, et al. Carbenoxolone inhibits DNA systhesis and collagen gene expression in rat hepatic stellate cells in culture. J Hepatol 2003;39:745–99.
- Chen A, Zhang L. The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factor-beta receptor. J Biol Chem 2003;278:23381–9.
- Sakata R, Ueno T, Nakamura T, Sakamoto M, Torimura T, Sata M. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. J Hepatol 2004;40:52–9.
- Chen YW, Li DG, Wu JX, Chen YW, Lu HM. Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-β in vitro via up-regulation of Smad 7. J Ethnopharmacol 2005;100:299–305.
- Lin YL, Lee TF, Huang YJ, Huang YT. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. J Pharm Pharmacol 2006;58:933–9.
- Wang JY, Zhang OS, Guo JS, Hu MY. Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol 2001;7:115–19.
- Dong MS, Jung SH, Kim HJ, Kim JR, Zhao LX, Lee ES, et al. Structure-related cytotoxicity and anti-hepatofibric effect of asiatic acid derivatives in rat hepatic stellate cell-line. Arch Pharm Res 2004;27:512–17.